These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

865 related items for PubMed ID: 15601392

  • 1. Effects of donepezil on Alzheimer's disease: the relationship between cognitive function and rapid eye movement sleep.
    Mizuno S, Kameda A, Inagaki T, Horiguchi J.
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):660-5. PubMed ID: 15601392
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
    Feldman H, Gauthier S, Hecker J, Vellas B, Xu Y, Ieni JR, Schwam EM, Donepezil MSAD Study Investigators Group.
    Int J Geriatr Psychiatry; 2005 Jun; 20(6):559-69. PubMed ID: 15920715
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
    Burns A, Gauthier S, Perdomo C.
    Int J Geriatr Psychiatry; 2007 Aug; 22(8):806-12. PubMed ID: 17199235
    [Abstract] [Full Text] [Related]

  • 4. A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease.
    Jones RW, Soininen H, Hager K, Aarsland D, Passmore P, Murthy A, Zhang R, Bahra R.
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):58-67. PubMed ID: 14716700
    [Abstract] [Full Text] [Related]

  • 5. Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.
    Wallin AK, Andreasen N, Eriksson S, Båtsman S, Nasman B, Ekdahl A, Kilander L, Grut M, Rydén M, Wallin A, Jonsson M, Olofsson H, Londos E, Wattmo C, Eriksdotter Jonhagen M, Minthon L, Swedish Alzheimer Treatment Study Group.
    Dement Geriatr Cogn Disord; 2007 Jan; 23(3):150-60. PubMed ID: 17312368
    [Abstract] [Full Text] [Related]

  • 6. Changes in cognitive functions of patients with dementia of the Alzheimer type following long-term administration of donepezil hydrochloride: relating to changes attributable to differences in apolipoprotein E phenotype.
    Kanaya K, Abe S, Sakai M, Fujii H, Iwamoto T.
    Geriatr Gerontol Int; 2010 Jan; 10(1):25-31. PubMed ID: 20102379
    [Abstract] [Full Text] [Related]

  • 7. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
    Passmore AP, Bayer AJ, Steinhagen-Thiessen E.
    J Neurol Sci; 2005 Mar 15; 229-230():141-6. PubMed ID: 15760632
    [Abstract] [Full Text] [Related]

  • 8. Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease.
    Waldemar G, Gauthier S, Jones R, Wilkinson D, Cummings J, Lopez O, Zhang R, Xu Y, Sun Y, Knox S, Richardson S, Mackell J.
    Int J Geriatr Psychiatry; 2011 Feb 15; 26(2):150-7. PubMed ID: 20597141
    [Abstract] [Full Text] [Related]

  • 9. Donepezil-induced sleep spindle in a patient with dementia with Lewy bodies: a case report.
    Ozaki A, Nishida M, Koyama K, Ishikawa K, Nishikawa T.
    Psychogeriatrics; 2012 Dec 15; 12(4):255-8. PubMed ID: 23279148
    [Abstract] [Full Text] [Related]

  • 10. One-year treatment of Alzheimer's disease with acetylcholinesterase inhibitors: improvement on ADAS-cog and TMT A, no change or worsening on other tests.
    Borkowska A, Ziolkowska-Kochan M, Rybakowski JK.
    Hum Psychopharmacol; 2005 Aug 15; 20(6):409-14. PubMed ID: 15991260
    [Abstract] [Full Text] [Related]

  • 11. Impact of donepezil hydrochloride on the care burden of family caregivers of patients with Alzheimer's disease.
    Hashimoto M, Yatabe Y, Kaneda K, Honda K, Ikeda M.
    Psychogeriatrics; 2009 Dec 15; 9(4):196-203. PubMed ID: 20377821
    [Abstract] [Full Text] [Related]

  • 12. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A, Imai Y, Tago H, Asada T, Shigeta M, Iwamoto T, Takita M, Arimoto I, Koma H, Takase T, Ohbayashi T.
    Dement Geriatr Cogn Disord; 2009 Dec 15; 27(3):232-9. PubMed ID: 19246907
    [Abstract] [Full Text] [Related]

  • 13. Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting.
    Wattmo C, Hansson O, Wallin AK, Londos E, Minthon L.
    Dement Geriatr Cogn Disord; 2008 Dec 15; 26(3):203-11. PubMed ID: 18769065
    [Abstract] [Full Text] [Related]

  • 14. Verbal repetition in patients with Alzheimer's disease who receive donepezil.
    Asp E, Cloutier F, Fay S, Cook C, Robertson ML, Fisk J, Dei DW, Rockwood K.
    Int J Geriatr Psychiatry; 2006 May 15; 21(5):426-31. PubMed ID: 16676290
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan.
    Nozawa M, Ichimiya Y, Nozawa E, Utumi Y, Sugiyama H, Murayama N, Iseki E, Arai H.
    Psychogeriatrics; 2009 Jun 15; 9(2):50-5. PubMed ID: 19604325
    [Abstract] [Full Text] [Related]

  • 17. Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer's disease.
    Tanaka M, Namiki C, Thuy DH, Yoshida H, Kawasaki K, Hashikawa K, Fukuyama H, Kita T.
    J Neurol Sci; 2004 Oct 15; 225(1-2):135-41. PubMed ID: 15465097
    [Abstract] [Full Text] [Related]

  • 18. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
    Kudoh C, Arita R, Honda M, Kishi T, Komatsu Y, Asou H, Mimura M.
    Psychogeriatrics; 2016 Mar 15; 16(2):85-92. PubMed ID: 25918972
    [Abstract] [Full Text] [Related]

  • 19. Donepezil for Alzheimer's disease.
    Benjamin B, Burns A.
    Expert Rev Neurother; 2007 Oct 15; 7(10):1243-9. PubMed ID: 17939763
    [Abstract] [Full Text] [Related]

  • 20. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
    Jelic V, Haglund A, Kowalski J, Langworth S, Winblad B.
    Dement Geriatr Cogn Disord; 2008 Oct 15; 26(5):458-66. PubMed ID: 18984956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.